Clinical cure in patients with hepatitis B cirrhosis treated with pegylated interferon α-2b: A case report
-
摘要:
<正>1病例资料患者女性,51岁。2009年体检时检出"大三阳"(HBs Ag、HBe Ag、抗-HBc阳性),余未见异常,未行药物治疗,定期门诊复查(具体情况不详)。2018年4月门诊查HBV DNA<10 IU/ml,HBs Ag 28. 8 IU/ml,HBe Ag 0. 29 S/CO,HBc Ab 8. 33 S/CO。腹部CT示:肝硬化,脾大;胆囊及胰腺未见异常。肝纤维化四项未见异常。肝功能:Alb 44. 0 g/L,ALT 26 U/L,AST 34 U/L,
-
Key words:
- hepatitis B /
- liver cirrhosis /
- polyethylene glycols /
- interferons
-
[1] Chinese Society of Hepatology and Chinese Society of Infectious Diseases,Chinese Medical Association. The guideline of prevention and treatment for chronic hepatitis B:A 2015 update[J]. J Clin Hepatol,2015,31(12):1941-1960.(in Chinese)中华医学会肝病学分会,中华医学会感染病学分会.慢性乙型肝炎防治指南(2015年更新版)[J].临床肝胆病杂志,2015,31(12):1941-1960. [2] Chinese Society of Infectious Disease,Chinese Society of Hepatology,Chinese Medical Association. The expert consensus on functional cure of chronic hepatitis B[J]. J Clin Hepatol,2019,35(8):1693-1701.(in Chinese)中华医学会感染病学分会,中华医学会肝病学分会.慢性乙型肝炎临床治愈(功能性治愈)专家共识[J].临床肝胆病杂志,2019,35(8):1693-1701. [3] YANG S,LI Y,QUAN M,et al. Response prediction in chronic hepatitis B patients with HBe Ag positive treated with 24weeks pegylated interferon therapy[J]. Chin J Liver Dis(Electronic Edition),2018,10(1):28-32.(in Chinese)杨松,李玥,全敏,等.聚乙二醇化干扰素治疗HBe Ag阳性慢性乙型肝炎患者24周的应答预测[J].中国肝脏病杂志(电子版),2018,10(1):28-32. [4] CHEN JL,YUAN ZH. Influence of interferon and nucleos(t)ide analogues on HBV cccDNA and functional cure of chronic hepatitis B[J]. J Clin Hepatol,2019,35(6):1181-1187.(in Chinese)陈捷亮,袁正宏.干扰素和核苷(酸)类似物治疗对HBV cccDNA的影响与慢性乙型肝炎的功能性治愈[J].临床肝胆病杂志,2019,35(6):1181-1187. [5] Chinese Society of Infectious Diseases,Chinese Medical Association; Chinese Society of Hepatology,Chinese Medical Association. Guidelines for the prevention and treatment of chronic hepatitis B(version 2019)[J]. J Clin Hepatol,2019,35(12):2648-2669.(in Chinese)中华医学会感染病学分会,中华医学会肝病学分会.慢性乙型肝炎防治指南(2019年版)[J].临床肝胆病杂志,2019,35(12):2648-2669.
计量
- 文章访问数: 1130
- HTML全文浏览量: 24
- PDF下载量: 167
- 被引次数: 0